City

Busan (1)

Guangzhou (1)

Condition

Angiosarcoma Metastatic (2)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 2 (2)

Sponsor

Sun Yat-sen University (1)

Sung Yong Oh (1)

Collaborator

Merck KGaA, Darmstadt, Germany (1)

Intervention

abraxane combined with liposomal doxorubicin (1)

avelumab (1)

paclitaxel (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

angiosarcoma metastatic

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Angiosarcoma Metastatic Trial in Guangzhou (Abraxane combined with liposomal doxorubicin)

Recruiting

Angiosarcoma Metastatic

Abraxane combined with liposomal doxorubicin

Guangzhou, Guangdong, China

Xing Zhang

Sep 4, 2022

Angiosarcoma Metastatic Trial in Busan (Avelumab, Paclitaxel)

Recruiting

Angiosarcoma Metastatic

Busan, Korea, Republic of

Sung Yong Oh

Jul 10, 2018